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Pentraxins constitute a superfamily of evolutionarily conserved 
proteins characterized by a cyclic multimeric structure1. In vivo  
functions for the classic short pentraxins C-reactive protein (CRP) 
and serum amyloid P component, produced mainly in the liver, have 
not been unequivocally defined because of considerable divergence 
between mouse and man in sequence and, most prominently, regu-
lation (CRP is not an acute-phase protein in mice)2. PTX3 is the first 
member of the long pentraxin family. Unlike the classic short pentra-
xins, this molecule is highly conserved between mouse and man in 
terms of sequence, ligand recognition and regulation3. Macrophages, 
dendritic cells and endothelial cells are major producers of PTX3 
in response to Toll-like receptor engagement4 and inflammatory 
cytokines5. Neutrophil-specific granules serve as a source of ready-
made PTX3 (ref. 6).
PTX3 has antibody-like functions, binding pathogens, activating 
and regulating complement and opsonizing particles1,4,7–12. In addi-
tion to having those recognition and effector functions, evidence 
exists showing that PTX3 can regulate inflammatory reactions13–15, 
as also reported for the classic short pentraxins16–19. In particular, 
PTX3-transgenic mice show greater resistance than wild-type mice 
to lipopolysaccharide toxicity and to cecal ligation and puncture13, 
whereas Ptx3−/− mice develop more myocardial damage associated 
with more neutrophil infiltration in a model of cardiac ischemia-
reperfusion injury15. However, the molecular basis for the reported 
regulatory function of pentraxins in general and PTX3 in particular 
in inflammatory reactions remains largely undefined.
The cell-migration process that causes leukocyte emigration to 
extravascular sites is essential to the innate and adaptive immune 
responses20. Leukocyte recruitment in acute and chronic inflamma-
tion entails a cascade of sequential cell-adhesion and cell-activation 
events, including tethering, rolling, adhesion, diapedesis, transmigra-
tion and chemotaxis21,22. The selectin family of cell-adhesion mol-
ecules consists of three calcium-dependent lectins: L-selectin (CD62L; 
A001417), which is constitutively expressed on most leukocytes; 
E-selectin (CD62E), which is expressed exclusively on endothelial cells 
after cytokine stimulation; and P-selectin (CD62P), which is stored 
on membranes of endothelial Weibel-Palade bodies and platelet 
α-granules20. Selectins interact with cell-surface glycoconjugates23 
and mediate leukocyte tethering and rolling, thereby bringing cir-
culating leukocytes into proximity with extracellular stimuli such as 
cytokines, chemokines and chemoattractants that are displayed on or 
released from activated endothelium24. After cells encounter inflam-
matory and thrombogenic stimuli, P-selectin rapidly relocates to the 
cell surface and binds P-selectin glycoprotein 1 (PSGL-1) expressed 
on leukocytes. This interaction mediates the tethering and rolling of 
both leukocytes and platelets on activated endothelial cells, as well 
as heterotypic aggregation between activated platelets and leuko-
cytes25. Extensive studies of mice lacking selectins have elucidated 
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Pentraxins are a superfamily of conserved proteins involved in the acute-phase response and innate immunity. Pentraxin 3 
(PTX3), a prototypical member of the long pentraxin subfamily, is a key component of the humoral arm of innate immunity that 
is essential for resistance to certain pathogens. A regulatory role for pentraxins in inflammation has long been recognized, but 
the underlying mechanisms remain unclear. Here we report that PTX3 bound P-selectin and attenuated neutrophil recruitment at 
sites of inflammation. PTX3 released from activated leukocytes functioned locally to dampen neutrophil recruitment and regulate 
inflammation. Antibodies have glycosylation-dependent regulatory effect on inflammation. Therefore, PTX3, which is an essential 
component of humoral innate immunity, and immunoglobulins share functional outputs, including complement activation, 
opsonization and, as shown here, glycosylation-dependent regulation of inflammation.
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a central role for P-selectin in leukocyte and platelet rolling and early 
leukocyte recruitment into inflammatory sites26–28.
In the context of a comprehensive effort to determine the PTX3 
interactome29, we sought to elucidate the mechanisms underlying the 
role of PTX3 in inflammation. Our focus was on the initial event of 
the inflammatory process: the rolling of leukocytes on inflamed blood 
vessels. We identified a selective, glycosylation-dependent interaction 
of PTX3 with P-selectin that dampened neutrophil recruitment at 
sites of inflammation.
RESULTS
PTX3 binds P-selectin
To determine whether PTX3 can interact with key molecules involved 
in leukocyte rolling, we assayed selectins for PTX3 binding. The short 
pentraxin serum amyloid P component has been shown to bind 
selectins, although the functional relevance of this interaction has not 
been determined30. In a microtiter plate assay, recombinant human 
PTX3 selectively bound recombinant human P-selectin and not E- or 
L-selectin (Fig. 1a). We examined the interaction of the short pen-
traxin CRP with selectins and found that CRP did not bind selectins 
in our experimental setting (Fig. 1b). We calculated an apparent dis-
sociation constant (Kd) of 360 ± 30 nM (mean of four experiments) 
for the binding of recombinant PTX3 to immobilized P-selectin when 
we added serial dilutions of biotinylated PTX3 to P-selectin-coated 
wells and evaluated the amount of bound PTX3 on the basis of a 
standard curve of the biotinylated protein (Fig. 1c).
We further characterized the binding of recombinant PTX3 to 
P-selectin by surface plasmon resonance (SPR). SPR studies showed 
that unlike the very fast association and dissociation rates that charac-
terize the interaction of P-selectin with its classic ligand PSGL-1 
(refs. 31,32), the binding of P-selectin to PTX3 was characterized by 
lower association (kon) and dissociation (koff) rate constants (kon, 
2.3 × 104 ± 0.7 × 104 M−1s−1, and koff, 2.9 × 10−3 ± 1.5 × 10−3 s−1) with 
a Kd of 123 nM (Fig. 1d). Human PTX3 purified from freshly isolated 
human neutrophils bound P-selectin (Fig. 2a) but not E-selectin or 
L-selectin (Supplementary Fig. 1). We estimated neutrophil-derived 
PTX3 to be at least ten times more potent in binding P-selectin than 
was recombinant PTX3 expressed by eukaryotic (Chinese hamster 
ovary (CHO)) cells in a series of four experiments. This difference 
was probably a reflection of heterogeneity that might have been due 
to differences in PTX3 glycosylation. Heterogeneity in the relative 
amount of bi-, tri- and tetra-antennary glycosylated structures, as 
well as that of variably sialylated oligosaccharides, has been observed 
among the different sources of PTX3 (ref. 33 and unpublished data). 
In severe inflammatory conditions, PTX3 is present in the circula-
tion at submicromolar concentrations34,35. Therefore, the affinity 
of PTX3 for P-selectin is compatible with its being relevant in vivo. 
Natural polymorphonuclear neutrophil (PMN)-derived PTX3 was 
more potent than recombinant PTX3, and higher effective concentra-
tions could be reached locally in the microcirculation. We therefore 
further characterized the PTX3–P-selectin interaction in vitro and 
its relevance in vivo.
Mapping of the interaction site on PTX3
The mature PTX3 protein is composed of two domains encoded by 
different exons. In a PTX3 monomer, a unique N-terminal domain, 
encoded by the second exon, is coupled to the pentraxin (C-terminal) 
domain, encoded by the third exon. Monomers can associate into 
octamers stabilized by disulfide bridges36. To better understand this 
interaction, we investigated which PTX3 domain is involved in the 
interaction with P-selectin. The recombinant C-terminal domain 
bound to P-selectin, whereas the N-terminal domain showed no 
binding (Fig. 2a). We confirmed the binding of the recombinant 
C-terminal domain of PTX3 to P-selectin by SPR (Fig. 2b). 
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Figure 1 Interaction of PTX3 with P-selectin. (a,b) Microtiter plate assay of the binding of PTX3 (220 nM; a) or CRP (470 nM; b) to plates coated with 
P-selectin (P), E-selectin (E) or L-selectin (L), presented as absorbance at 450 nm (A450). C1q serves as a positive control. Results are from three 
independent experiments (mean and s.d. of duplicate or triplicate wells). (c) Affinity of the interaction between P-selectin immobilized on microtiter 
wells and various amounts of biotinylated PTX3 (bPTX3); specific binding was measured in accordance with a standard curve of bPTX3, with nonlinear 
fitting analysis. Inset, Scatchard plot of binding data. Data are representative of four experiments (error bars, s.d.). (d) SPR analysis of the binding of 
100, 300 and 900 nM P-selectin injected onto immobilized PTX3. Sensorgrams were fitted by the 1:1 interaction model (white lines) to obtain the 
corresponding association and dissociation rate constants (kon and koff) and are presented as time course of the SPR signal in resonance units (RU). 
Data are representative of two experiments.
Figure 2 Binding site for P-selectin on PTX3. (a) Microtiter plate assay  
of the binding of recombinant PTX3 (R; 220 nM), its recombinant  
C- and N-terminal domains (C (220 nM) and N (220 nM), respectively) 
and PMN-derived PTX3 (PMN; 5 nM) to P-selectin. Results are from 
three independent experiments (mean and s.d. of duplicate or triplicate 
wells). (b) SPR analysis of the binding of 165, 325, 650 and 1300 nM 
P-selectin injected onto the immobilized C-terminal domain of PTX3, 
presented as the time course of the SPR signal. Sensorgrams were fitted 
by a model that included two different Kd values (white lines). Data are 
representative of two experiments.
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Sensorgrams could not be adequately fitted by the 1:1 interaction 
model and required a more complex equation. A model that included 
two different Kd values (probably due to some conformational hetero-
geneity of the immobilized protein) resulted in good fitting of experi-
mental data; the Kd values obtained by analysis of 11 sensorgrams 
(with P-selectin concentrations ranging from 100 to 1,300 nM) 
were as follows: 78 nM (kon, 2.9 ± 0.8 × 104 M−1s−1; koff, 2.2 ± 0.7 ×  
10−3 s−1) and 430 nM (kon, 10.2 ± 7 × 104 M−1s−1; koff, 3.2 ± 0.9 × 
10−2 s−1). Thus, the PTX3–P-selectin interaction is mediated by the 
pentraxin domain of PTX3.
The importance of the glycosidic moiety
The C-terminal domain of PTX3 contains a single N-glycosylation 
site on Asn220 linked to fucosylated and sialylated biantennary 
complex–type sugars33. Because selectins bind to carbohydrate moieties 
that are present on certain carrier molecules37, we tested the 
involvement of the PTX3 glycosidic moiety. Both enzymatic 
deglycosylation of PTX3 and site-directed mutagenesis of its 
glycosylation-carrying residue (Asn220 to Gln220) resulted in 
binding to P-selectin that was 70% lower (Fig. 3a). Deglycosylated 
PTX3 remained functional in other assays: it bound C1q (the 
first component of the classical complement cascade), the extra-
cellular matrix protein TSG6 and microbial moieties at least as 
efficiently as the native molecule did33 (Supplementary Fig. 2). 
We next assessed whether PSGL-1 can compete with PTX3 for 
binding to P-selectin. Indeed, the addition of PSGL-1 to the assay 
diminished the binding of PTX3 to P-selectin in a dose-dependent 
manner (Fig. 3b and Supplementary Fig. 3). PTX3 did not bind 
PSGL-1 in the same experimental conditions (Supplementary Fig. 4). 
In the in vitro system used, consisting of a PSGL-1 fusion protein and 
polyclonal antibodies, recombinant PTX3 failed to efficiently displace 
binding to P-selectin, most probably because of the lower kon value, 
as discussed above (data not shown). This finding may indicate that 
PTX3 derived from arrested PMNs will not interfere in an autocrine 
way with the adhesive and signaling functions of PSGL-1. Together 
these data suggest that PTX3 acts as a competitive inhibitor of the 
P-selectin–PSGL-1 interaction.
The PTX3–P-selectin interaction in a cell-based context
Having characterized the biochemical properties of the PTX3–P-selectin 
interaction, we next assessed whether PTX3 bound P-selectin in a 
more physiological context. PTX3 bound in a dose-dependent manner 
to P-selectin-transfected CHO cells (Fig. 4a), whereas we observed no 
binding to untransfected or irrelevant protein–transfected CHO cells 
(Supplementary Fig. 5). Furthermore, thrombin-activated platelets 
expressing P-selectin bound PTX3, and this binding was inhibited by 
function-blocking antibody to P-selectin (anti-P-selectin; Fig. 4b), 
which suggested a physiological relevance for this interaction.
P-selectin is stored in Weibel-Palade bodies of endothelial cells, and 
after activation, it relocates rapidly to the cell surface, where it has an 
essential role in the early stages (tethering and rolling) of leukocyte 
recruitment38. Together the data presented above suggested that PTX3 
might compete with leukocyte PSGL-1 for P-selectin binding during 
the initial steps of the leukocyte extravasation cascade. We addressed 
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Figure 3 The role of the PTX3 glycosidic moiety in the PTX3– 
P-selectin interaction. (a) Binding of untreated PTX3 (PTX3;  
220 nM), enzymatically deglycosylated PTX3 (DG; 220 nM) or  
PTX3 deglycosylated by site-directed mutagenesis (MUT; 220 nM) to  
P-selectin-coated wells. Results are from four independent experiments 
(mean and s.d. of duplicate wells). (b) Binding of PTX3 (110 nM)  
to P-selectin-coated wells in the presence of increasing doses of 
recombinant PSGL-1, presented as percentage of binding in the  
absence of PSGL-1. Results are from four independent experiments 
(mean ± s.d. of duplicate wells).
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Figure 4 PTX3 binds P-selectin in a cell-based context. (a) Binding of 
PTX3 to P-selectin-transfected CHO cells, assessed by flow cytometry. 
Results are presented as the percentage of maximum (% of max) to 
allow the presentation of normalized data and represent the number of 
events in each bin divided by the number of events in the bin with the 
largest number of cells. PE-A (horizontal axis), area under the curve for 
the intensity of phycoerythrin fluorescence. Mean fluorescence intensity 
(MFI): streptavidin-phycoerythrin (Strep-PE), 119.62; 220 nM PTX3, 
996.02; 440 nM PTX3, 2309.71; 2,200 nM PTX3, 5768.92. Data are 
representative of two independent experiments. (b) Binding of PTX3  
(1 µM) to resting or thrombin-activated platelets in the presence or 
absence of a monoclonal P-selectin-blocking antibody (mAb to P-sel  
(CLB-Thromb/6); 20 µg/ml), assessed by flow cytometry. *P < 0.001 
(one-way analysis of variance (ANOVA)). Data are representative of three 
experiments (mean and s.d.). (c) Analysis of leukocyte rolling on  
P-selectin- and E-selectin-coated glass capillary tubes in the presence  
of increasing doses of PTX3; results were recorded for single areas of  
0.2 mm2 for at least 30 s. Rolling interactions (corresponding to 
interactions lasting less than 0.5 s) were considered important and  
were given scores. Data are from five experiments with five to seven  
areas analyzed in each (mean and s.d.).
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this hypothesis in an in vitro rolling assay. The rolling of freshly iso-
lated human neutrophils on P-selectin-coated glass capillaries under 
a shear stress of 2 dyne/cm2 was strongly inhibited by pretreatment 
of the coated capillaries with PTX3 (Fig. 4c). PTX3 pretreatment had 
little effect on E-selectin-mediated rolling in vitro. PTX3 itself did not 
support the rolling of neutrophils or monocytes under shear stress 
when it was coated onto glass capillaries (data not shown). Thus, PTX3 
blocks the rolling of leukocytes on P-selectin in an in vitro setting.
In vivo analysis of leukocyte rolling
Next we addressed the role of PTX3 in leukocyte rolling in vivo. We 
made a comparative analysis of rolling by intravital microscopy of 
thrombin-stimulated mesenteric venules. This analysis showed that 
Ptx3−/− mice had significantly (71%) more rolling interactions than 
did wild-type mice (Fig. 5a and Supplementary Table 1). Moreover, 
the administration of PTX3 to wild-type mice consistently attenu-
ated the frequency of rolling interactions (55% inhibition; Fig. 5 
and Supplementary Table 2). The strength and quality of rolling 
interactions (frequency distributions of rolling velocities) were 
not influenced much by genetic deficiency or PTX3 administration 
(Supplementary Fig. 6 and Supplementary Tables 1 and 2). These 
data show that endogenously secreted PTX3 can indeed affect leuko-
cyte rolling in vivo and suggest that PTX3 can attenuate extravasation 
under pathological conditions.
Exogenous PTX3 blocks PMN recruitment in vivo
The results discussed above suggested that PTX3 may exert an anti-
inflammatory effect in P-selectin-dependent models of leukocyte 
recruitment and inflammation. The recruitment of neutrophils into 
the pleural cavity during the early stages of pleural inflammation in 
response to the CXC chemokine KC (CXCL1; A003780) is dependent 
on P-selectin and L-selectin39, and we adapted this model to test the 
in vivo functional consequences of the PTX3–P-selectin interaction40. 
Treatment with PTX3 resulted in 73% less accumulation of neutro-
phils measured at 2 h after injection of KC into the pleural cavity 
(Fig. 6a). The effect was dose dependent (Supplementary Fig. 7a). 
Exogenously administered PTX3 was rapidly cleared from the circula-
tion with a half-life of 1 h (Supplementary Fig. 8). PTX3 administered 
1 h after KC injection had no substantial activity. As expected on 
the basis of high sequence similarity between the human and mouse 
proteins1, mouse PTX3 was also an effective inhibitor of leukocyte 
recruitment in this model (Supplementary Fig. 9). The inhibitory 
effect of PTX3 was similar to that of the P-selectin-blocking antibody 
(Fig. 6a). Heat inactivation of PTX3 before administration abrogated 
the inhibitory effect of the intact molecule (Fig. 6a). In addition, lack 
of PTX3 glycosylation due to site-directed mutagenesis of Asn220 also 
reversed the inhibitory effect of the wild-type molecule, an observa-
tion consistent with in vitro data on the involvement of the sugar 
moiety (Fig. 6a). Notably, treatment with the C-terminal domain 
of recombinant PTX3 impaired early neutrophil recruitment simi-
larly to the full-length protein (Fig. 6a), which suggested that the C 
terminus is sufficient for this anti-inflammatory effect of PTX3. We 
did not observe the inhibitory effect of PTX3 on recruitment in the 
presence of P-selectin-blocking antibody or in P-selectin-deficient 
mice (Fig. 6b). In addition, the inhibitory effect of PTX3 was repro-
duced when we used lipopolysaccharide as the inflammatory stimulus 
instead of KC (Fig. 6c). Time-course experiments showed that treat-
ment with PTX3 caused an overall lower PMN accumulation in the 
pleurisy model over 18 h, by which time neutrophil numbers returned 
to baseline (Supplementary Fig. 7b). These data suggest that PTX3 
attenuates, rather than simply delaying, the accumulation of neutro-
phils at sites of inflammation. Using bone marrow chimeras, we found 
that P-selectin-deficient mice reconstituted with either P-selectin-
deficient or wild-type bone marrow showed impairment of PMN 
recruitment (data not shown), which suggested that platelets do not 
have a role in the pleurisy model. Further work with the appropriate 
models (such as experimental atherosclerosis) is needed to investigate 
the importance of the recognition of platelet P-selectin by PTX3.
Hematopoietic cell–derived PTX3 dampens PMN extravasation
PTX3 is stored in neutrophil-specific granules and is released 
after PMN degranulation6, and it is also produced by diverse cell 
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types, including endothelial cells, after inflammatory stimuli5,41,42. 
To evaluate the effect of endogenous PTX3 on leukocyte recruitment, 
we assessed the magnitude of neutrophil influx in Ptx3−/− mice in 
the pleural inflammation model. Ptx3−/− mice showed significantly 
more neutrophil accumulation than did wild-type mice (Fig. 7a). This 
phenotype was reversed by treatment with exogenous PTX3 (Fig. 7a). 
In an effort to delineate the relative contributions of hematopoietic 
cell–derived PTX3 and stromal cell–derived PTX3, we used bone 
marrow chimeras. Wild-type mice that received Ptx3−/− bone 
marrow showed more neutrophil influx than did mice transplanted 
with wild-type bone marrow, a phenotype resembling that of Ptx3−/− 
mice (Fig. 7b). Conversely, in Ptx3−/− mice that received wild-type 
bone marrow, the number of recruited cells was similar to that of wild-
type mice (Fig. 7b). The localization of PTX3 in neutrophil granules 
is selective in that eosinophils, basophils, platelets, natural killer cells 
and endothelial cells are negative for this6. Moreover, chemokines 
do not induce gene expression–dependent production of PTX3 in 
monocytes and dendritic cells3. Therefore, these results suggest that 
in the pleurisy model, at least at early time points, neutrophils are 
the main source of PTX3, which acts as a negative feedback loop for 
PMN recruitment.
PTX3 dampens PMN recruitment in acute lung injury
P-selectin has long been known to be involved in some models of 
inflammatory recruitment of neutrophils into the lung43. Acute lung 
injury, which leads to acute respiratory distress syndrome, is a com-
mon disease with an incidence of 79 per 100,000 person-years in the 
United States44. Despite the use of state-of-the-art treatment, this 
disease is associated with high mortality (up to 38%). Pneumonia 
and acid aspiration are typical causes of intrapulmonary acute lung 
injury. The recruitment of PMNs into the lungs is a key event in 
the development of this disorder45. Studies suggest that P-selectin-
mediated platelet-neutrophil interactions are a chief contributor to 
acid-induced recruitment of PMNs and lung damage. In a mouse model 
of acid-induced acute lung injury (a model of acute respiratory distress 
syndrome), it has been demonstrated that blocking of P-selectin 
decreases the development of experimental early acid-induced acute 
lung injury46. We investigated whether PTX3 could also block P-selectin- 
mediated neutrophil extravasation in this animal model. Indeed, 
treatment with PTX3 before the induction of lung damage resulted 
in less accumulation of neutrophils in the lung (Fig. 8a), as well 
as less migration of neutrophils into the bronchoalveolar space 
(Fig. 8b), similarly to treatment with anti-P-selectin. Ptx3−/− mice 
showed greater susceptibility to acid-induced lung injury in terms 
of wasting and lung function (in one experiment; Supplementary 
Fig. 10). For example, on day 2, loss of body weight was 4% ± 0.6% 
(mean ± s.e.m.) and 12% ± 1% in wild-type mice (n = 9) and Ptx3−/− 
mice (n = 17), respectively, and this effect was reversed by exogenous 
PTX3. Similarly, lung compliance was 1.52 ± 0.07 (mean ± s.e.m.) 
for wild-type mice (n = 12) and 1.70 ± 0.03 for PTX3-treated mice 
(n = 12; P = 0.03). Together these results suggest that PTX3 released 
from cells of bone marrow origin, most probably neutrophils, acts as 
a negative feedback mechanism that dampens P-selectin-dependent 
recruitment of leukocytes.
DISCUSSION
Leukocyte infiltration can function as a double-edged sword, causing 
not only the mobilization of defense and tissue-repairing elements 
but also further tissue damage, as observed in ischemia-reperfusion 
injury, shock, systemic septicemia, transplantation and acute lung 
injury. Our results presented here have shown that the long pentraxin 
PTX3 selectively bound P-selectin via its N-linked glycosidic moiety 
located in the third exon–encoded pentraxin domain. Using three 
in vivo models of P-selectin-dependent inflammation (pleurisy, acid-
induced acute respiratory distress syndrome and intravital microscopy 
analysis of mesenteric inflammation), we found that exogenous PTX3 
and endogenous PTX3 released from hematopoietic cells acted as 
a negative feedback loop, preventing excessive P-selectin-dependent 
recruitment of neutrophils. Our results suggest that under conditions 
of massive leukocyte activation, the release of PTX3 acts locally as a 
negative feedback mediator, dampening neutrophil recruitment. It is 
likely that this pathway underlies the long-known regulatory role of 
PTX3 in inflammation. Our findings may affect the optimization and 
exploitation of the antimicrobial activity of pentraxins.
Our study here and published studies have suggested that the 
fluid-phase pattern-recognition molecule PTX3 can act as double- 
edged sword. After binding to microbial moieties4,10–12, it has 
opsonic activity, activates complement and enhances leukocyte 
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Figure 8 PTX3 dampens PMN recruitment in a model of acid-induced 
acute lung injury. (a) PMN infiltration of lung interstitium at 3 h after 
acid-induced acute lung injury (HCl) in mice pretreated intravenously with 
vehicle (0.9% saline solution; n = 13), PTX3 (100 µg/mouse; n = 16) 
or P-selectin-blocking antibody (30 µg/mouse; n = 6). (b) Migration of 
neutrophils into the bronchoalveolar space at 3 h after acid-induced acute 
lung injury in mice pretreated intravenously with vehicle (0.9% saline 
solution; n = 7), PTX3 (100 µg/mouse; n = 8) or P-selectin-blocking 
antibody (30 µg/mouse; n = 6). *P < 0.05 and **P < 0.01 (one-way 
ANOVA). Data are representative of two experiments (mean and s.e.m.).
Figure 7 Role of endogenous PTX3 in leukocyte recruitment. (a) Recruitment 
of PMNs into the pleural cavity of wild-type and PTX3-deficient mice pretreated 
intravenously with vehicle (0.9% saline solution; wild type, n = 16; PTX3-
deficient, n = 16) or PTX3 (PTX3-KO + PTX3; 100 µg/mouse; n = 13).  
(b) Recruitment of PMNs into the pleural cavity of lethally irradiated wild-type (WT) 
and PTX3-deficient (KO) mice that received wild-type or PTX3-deficient 
bone marrow (wild type→wild type, n = 13; PTX3-deficient→wild type,  
n = 20; wild type→PTX3-deficient, n = 12; PTX3-deficient→PTX3-deficient,  
n = 11). *P < 0.05, **P < 0.01 and ***P < 0.001 (one-way ANOVA). Data  
are representative of two experiments (a) or one experiment (b; mean and s.e.m.).
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recruitment7. However, as shown here, PTX3 can act as a regulatory 
molecule of innate immunity and inflammation by dampening exces-
sive neutrophil recruitment. The results presented here suggest two 
scenarios in which PTX3 can exert a regulatory effect on inflamma-
tory reactions. In localized inflammatory reactions, degranulation of 
neutrophils results in local PTX3 in the microcirculation, which, by 
binding P-selectin with a low dissociation rate (koff, 2.9 × 10
−3 s−1), 
dampens excessive recruitment. In contrast, under conditions of 
systemic inflammation, such as sepsis and acute respiratory distress 
syndrome, high concentrations of circulating PTX3, reflecting release 
from degranulating neutrophils as well as gene expression–dependent 
production, can act systemically as a negative feedback loop.
PTX3 is a component of the humoral arm of the innate immune 
system that is conserved in evolution and is endowed with an essential 
role in resistance to certain pathogens, such as Aspergillus fumigatus 
and influenza virus11,47. It binds microbial moieties4, orchestrates 
complement activation8,9 and has opsonic activity10. Therefore, it 
acts as a functional predecessor of antibodies (an ‘ante-antibody’). 
The finding of a regulatory function mediated by the glycosidic moi-
ety is reminiscent of a similar activity of immunoglobulins48. Thus, 
immunoglobulins and components of the humoral arm of the innate 
immune system, such as pentraxins, although they are genetically and 
structurally different, share fundamental functional outputs, including 
agglutination, complement activation, opsonization and, as reported 
here, glycosylation-dependent regulation of inflammation.
METHODS
Methods and any associated references are available in the online version 
of the paper at http://www.nature.com/natureimmunology/.
Accession codes. UCSD-Nature Signaling Gateway (http://www. 
signaling-gateway.org): A001417 and A003780.
Note: Supplementary information is available on the Nature Immunology website.
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ONLINE METHODS
Proteins. Recombinant human and mouse PTX3 and the PTX3 C-terminal 
and N-terminal domains were purified under endotoxin-free conditions by 
immunoaffinity, ion-exchange chromatography and gel filtration, respec-
tively, from the supernatants of stably transfected CHO cells as described14. 
Enzymatically deglycosylated PTX3 was obtained as described26. All proteins 
were at least 95% pure as assessed by SDS-PAGE followed by silver staining. 
PTX3 was deglycosylated by site-directed mutagenesis (Tecnogen). Recombinant 
human P-selectin, E-selectin, L-selectin and the PSGL-1–Fc chimera 
were from R&D Systems. Polyclonal antibody to PTX3 was prepared by 
 immunization of rabbits with purified human recombinant PTX3. Function-
blocking monoclonal antibody to mouse P-selectin (Rb40.34)49 was a gift 
from D. Vestweber.
Cells. P-selectin-transfected CHO cells were a gift from G. Kansas. 
Untransfected CHO cells (American Type Culture Collection) and D6- 
transfected CHO cells (a gift from M. Locati) served as control cells for bind-
ing experiments. Venous blood was collected from healthy volunteers (after 
informed consent was provided) as approved by the Ethical Committee of 
Istituto Clinico Humanitas. Blood was drawn with an 18-gauge needle and 
dripped freely into open tubes containing 3.8% (vol/vol) sodium citrate (1:9, 
sodium citrate/blood). Tubes were centrifuged for 15 min at 100g. Platelet-rich 
plasma was collected and platelets were washed once (10 min at 300g) and 
resuspended in HEPES Tyrode buffer, pH 7.4, containing CaCl2 (2.5 mM). 
Human neutrophils were purified from the blood of healthy donors by density 
gradients as described11.
Animals. Ptx3−/− mice were generated as described3 and were used on a 
C57BL/6J or 129/Sv inbred genetic background matched with the appropriate 
wild-type controls (Charles River Laboratories). P-selectin-deficient mice (on 
a C57BL/6 genetic background) were a gift from V. Evangelista. Procedures 
involving animals and their care conformed with institutional guidelines in 
compliance with national laws and policies (Decretto Legge number 116, 
Gazzetta Ufficiale supplement 40, 18-2-1992) and international laws and 
policies (European Economic Community Council (1987), Directive 86/609, 
Official Journal of European Communities, Law 358,1; National Institutes 
of Health Guide for the Care and Use of Laboratory Animals, US National 
Research Council 1996). Mice were housed in the specific pathogen–free 
 animal facility of the Istituto Clinico Humanitas in individually ventilated 
cages and were used between 6 and 12 weeks of age.
Microtiter plate assays. Microtiter plates (Nunc) were coated with P-selectin, 
E-selectin, L-selectin or C1q (each at a concentration of 5 µg/ml) in PBS2+ 
phosphate buffer (containing CaCl2 (130 mg/l) and MgCl2 (100 mg/l); 
Lonza) by overnight incubation at 4 °C. Nonspecific binding to the plates 
was blocked by incubation for 2 h at 25 °C with 5% (wt/vol) dry milk in 
PBS. All reaction volumes were 100 µl and plates were washed after each step 
with PBS2+ containing 0.05% (vol/vol) Tween-20. Single binding experi-
ments and concentrations of ligands are noted in the figure legends. Binding 
was detected by incubation with polyclonal rabbit antibody to human PTX3 
(1:2,000 dilution; made ‘in-house’), followed by horseradish peroxidase–
conjugated secondary antibody to the species (Jackson ImmunoResearch). 
Tetramethylbenzidine substrate (Sigma) was used, and absorbance was 
measured at 450 nm.
SPR. The ProteOn XPR36 Protein Interaction Array system (Bio-Rad) 
was used for binding studies. Full-length human PTX3 and its C-terminal 
domain were covalently immobilized onto two flow cell surfaces of the same 
Proteon GLC sensor chip (Bio-Rad) by standard amine-coupling protocols. 
For the immobilization step, the ligands were diluted to a final concentra-
tion of 20–30 µg/ml in acetate buffer (pH 2.5 for PTX3; pH 3.7 for the 
PTX3 C-terminal domain). The amount of PTX3 or the PTX3 C-terminal 
domain covalently immobilized on the surface, presented as resonance 
units (1 resonance unit = 1 pg protein/mm2), was about 2,000–3,000 or 
1,000–2,000, respectively. A reference channel was always prepared in para-
llel by the same activation-deactivation procedure but with the injection of 
vehicle only. The analyte running buffer was Tris-HCl, pH 7.4, containing 
150 mM NaCl, 1.2 mM CaCl2 and 0.005% (vol/vol) Tween 20. P-selectin 
was injected over immobilized ligands for 2–3 min at a rate of 30 µl/min (asso-
ciation phase), and dissociation was measured in the subsequent 10–15 min. 
Vehicle (running buffer) was always injected in parallel flow channels. 
Where needed, complete dissociation of bound analytes was induced by a 
30-second injection with 2 M NaCl (regeneration step). ProteOn analysis 
software was used for analysis of sensorgrams.
Flow cytometry. Purified human platelets (1 × 108 platelets per sample), 
resting or activated with thrombin (1 U/ml; Sigma), were incubated for 
30 min at 25 °C with 1 µM biotinylated PTX3 in the presence or absence of 
function-blocking monoclonal antibody to human P-selectin (20 µg/ml; CLB-
Thromb/6; Immunotech). Samples were then washed with HEPES Tyrode 
buffer, pH 7.4, and were fixed with PBS containing 1% (vol/vol) formaldehyde. 
After being stained with allophycocyanin-conjugated streptavidin, samples 
were analyzed with a FACSCanto (BD) and FACSDiva software (BD). In 
another set of experiments, the binding of various doses of biotinylated PTX3 
to P-selectin-transfected, D6-transfected and untransfected CHO cells (all 
at a density of 1 × 106 cells per sample) was evaluated. After 1 h of incuba-
tion at 4 °C, samples were washed, stained with phycoerythrin-conjugated 
streptavidin and analyzed with a FACSCanto (BD), FACSDiva software (BD) 
and FlowJo software.
Leukocyte rolling assay. Microcap glass capillary tubes (100 µl; Drummond) 
were coated for 10 h at 4 °C with 20 µl human E-selectin or P-selectin (1 µg/ml 
dissolved in PBS; R&D Systems); some tubes coated previously with E-selectin 
or P-selectin were also further coated for 16 h with 20 µl PTX3 (various 
concentrations dissolved in PBS). Immediately before use, tubes were washed 
extensively and human PMNs, resuspended at a density of 0.5 × 106 cells per ml, 
a solution of 2 mM Ca2+ and Mg2+ and 10% (vol/vol) FCS in PBS, were fluxed 
into the tubes at a shear stress of 2 dyne/cm2. The activity of interacting cells 
was recorded on S-VHS videotape and was analyzed frame by frame by 
computer-assisted digital analysis50. Single areas of 0.2 mm2 were recorded for 
at least 30 s. Rolling interactions (corresponding to interactions lasting less 
than 0.5 s) were considered important and were assigned scores.
Bone marrow transplantation. C57BL/6J wild-type or Ptx3−/− mice were 
lethally irradiated with a total dose of 900 cGy. Then, 2 h later, mice were 
injected in the tail vein with 5 × 106 nucleated bone marrow cells obtained by 
flushing of the cavity of a freshly dissected femur from a wild-type or Ptx3−/− 
donor. Recipient mice received gentalyn (0.4 mg/ml in drinking water) starting 
10 d before irradiation and maintained thereafter. At 8 weeks after bone mar-
row transplantation, the pleural inflammation model was generated.
Pleural inflammation. Intrapleural injection of KC (CXCL1), a known model 
of the migration of neutrophils into pleural cavity, has been described29. Wild-
type or Ptx3−/− 129/Sv or C57BL/6J mice were injected intrapleurally with 
50 µl sterile PBS or 0.1 µg recombinant mouse KC (R&D Systems) and were 
killed after 2 h. All cells in the pleural fluid were collected by washing of the 
cavity with 1 ml RPMI medium. Cells were counted in a Burker chamber with 
Turk’s stain. Differential cell counts were made according to standard mor-
phologic criteria to identify cell types in cytospin preparations (Cytospin 4 
Cytocentrifuge; Shandon) stained with the Diff-Quik staining kit (Medion 
Diagnostics). At least 400 cells were counted in each sample.
Acid-induced acute lung injury. Mice anesthetized by intraperitoneal injec-
tion of 2.5% Avertin (400 mg per kg body weight; Tribromoethanol, Sigma-
Aldrich) were intubated orotracheally with a 22-gauge angiocatheter and 
ventilated with tidal volume of 8–10 ml per kg body weight at a respiratory rate 
of 130 min−1 and an FiO2 (fraction of inspired oxygen) of 0.21 and without 
positive end-expiratory pressure. A 26-gauge plastic cannula was introduced 
through a tracheotomy and mice received HCl, pH = 1.5 (2 ml per kg body 
weight) or 0.9% saline. Mechanical ventilation was stopped 10 min after instil-
lation and mice were extubated and placed in an oxygenated chamber (FiO2 
0.5) for 3 h. After mice were killed, bronchoalveolar lavage fluid was collected 
(three lavages with 1 ml RPMI medium each). All cells in the bronchoalveolar 
lavage fluid were counted in a Burker chamber and differential cell counts were 
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done as described above. After bronchoalveolar lavage fluid was collected, the 
inferior vena cava was opened and nonadherent PMNs were dislodged from 
the pulmonary vasculature by the flushing of 5 ml PBS through the right 
ventricle. Lungs were removed and minced, and samples were incubated for 
30 min at 37 °C with collagenase type IV (Sigma). Cells were collected after 
passage through a cell strainer (BD Biosciences) and lysis of red blood cells. 
Total lung cells were counted in a Burker chamber and differential cell counts 
were done as described above.
Intravital microscopy in mesenteric venules. Female C57BL6/J (wild-
type) and Ptx3−/− mice 6–8 weeks of age were housed and used according 
to European Community rules for the use of laboratory animals. Mice were 
anesthetized by intraperitoneal injection of physiological saline (10 ml per 
kg body weight) containing ketamine (5 mg/ml) and xylazine (1 mg/ml). 
A heparinized polyethylene catheter (PE50; internal diameter, 0.58 mm; Becton 
Dickinson) was inserted in the lateral tail venule with a 25-gauge needle. 
After the abdominal fur was shaved, a midline incision was made through 
the skin and peritoneum. Mice were placed on one side and a segment of the 
terminal ileum with its accompanying mesentery was exteriorized through 
the abdominal incision. All exposed tissue was irrigated with phosphate buffer 
containing thrombin from bovine plasma (0.5 U/ml; Sigma) and was covered 
with a glass slide to minimize tissue dehydration. All parts of the intestine that 
were not observed microscopically were covered with soaked cotton pads. The 
recipient was maintained at 37 °C with a stage-mounted Linkam CO102 strip 
heater (Olympus) as described51. The preparation was placed on a BX50WI 
microscope (Olympus). The mesenteric vascular bed was visualized with a 
16× objective. After 30 min of stimulation with thrombin, PMNs were slowly 
injected through the catheter. PMNs were suspended at a density of 30 × 106 
cells per ml in DMEM without sodium bicarbonate, supplemented with 
20 mM HEPES, pH 7.1 and 5% (vol/vol) FCS and were labeled for 10 min 
at 37 °C with orange fluorescent tetramethylrhodamine (Molecular Probes). 
Images were visualized with a silicon-intensified target video camera (VE-1000 
SIT; Dage-MTI) and a Sony SSM-125CE monitor. Recordings were digitalized 
and stored on videotapes with a digital VCR (Panasonic NV-DV10000) and 
Casablanca digital system (MS MacroSystem Computer). Three to six venules 
(25–55 mm in diameter) were selected in each experiment and a 250-mm 
length of each venule was observed throughout the experiment.
Video analysis was made by playback of digital videotapes in real time 
or at lower speed, and frame by frame. Vessel diameter (D), hemodynamic 
 parameters and the velocity of rolling were determined with Image 1.62 soft-
ware (National Institutes of Health). The velocity of 20 or more consecutive 
freely flowing cells per venule was calculated, and from the velocity of the fast-
est cell in each venule (Vfast), the mean blood flow velocity (Vm) was calculated 
as Vm = Vfast / (2 – ε2), where ε is the ratio of lymphocyte diameter to vessel 
diameter. The wall shear rate (WSR) was calculated as WSR = 8 × Vm / D (s
−1), 
and the shear stress (WSS) acting on rolling cells was approximated by WSR × 
0.025 (dyn/cm2), with the assumption of a blood viscosity of 0.025 Poise. 
Leukocytes were considered to be rolling if they traveled at a velocity below 
the critical velocity (Vcrit = Vm × ε × (2 – ε))52. At least 150 consecutive cells 
per venule were examined. Rolling fractions were defined as the percentage 
of cells that rolled within a given venule among the total number of cells that 
entered that venule during the same period53.
Statistical analysis. Data were compared by one-way ANOVA followed by the 
Newman-Keuls multiple comparison test with Prism software (version 4.00 
for Windows; GraphPad) or with the paired or unpaired two-tailed Student’s 
t-test.
Additional methods. Information on the preparation of PMNs for intravital 
microscopy and the assessment of pressure-volume curves is available in the 
Supplementary Methods.
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